A Phase 1B Study of Dulanermin in Combination With Modified FOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer.
| Autor: | Wainber, Zev A., Messersmith, Wells A., Peddi, Parvin F., Kapp, Amy V., Ashkenazi, Avi, Royer-Joo, Stephanie, Portera, Chia C., Kozloff, Mark F. |
|---|---|
| Zdroj: | Clinical Colorectal Cancer; Dec2013, Vol. 12 Issue 4, p248-254, 7p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Full Text from ScienceDirect